Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Other Non-Current Assets (2018 - 2025)

Historic Other Non-Current Assets for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to $1.9 million.

  • Arcturus Therapeutics Holdings' Other Non-Current Assets changed 0.0% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.9 million for FY2024, which is 9657.27% down from last year.
  • According to the latest figures from Q3 2025, Arcturus Therapeutics Holdings' Other Non-Current Assets is $1.9 million, which was down 0.0% from $1.9 million recorded in Q2 2025.
  • In the past 5 years, Arcturus Therapeutics Holdings' Other Non-Current Assets registered a high of $55.0 million during Q4 2023, and its lowest value of $107000.0 during Q1 2021.
  • Moreover, its 5-year median value for Other Non-Current Assets was $2.1 million (2021), whereas its average is $6.5 million.
  • As far as peak fluctuations go, Arcturus Therapeutics Holdings' Other Non-Current Assets surged by 252655.21% in 2023, and later tumbled by 9657.27% in 2024.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Other Non-Current Assets (Quarter) stood at $2.1 million in 2021, then rose by 0.82% to $2.1 million in 2022, then skyrocketed by 2526.55% to $55.0 million in 2023, then crashed by 96.57% to $1.9 million in 2024, then changed by 0.0% to $1.9 million in 2025.
  • Its last three reported values are $1.9 million in Q3 2025, $1.9 million for Q2 2025, and $18.4 million during Q1 2025.